Senior Scientist, Methodological & Implementation Research
Ottawa Hospital Research Institute

Scientific Lead, Health Economics, The Ottawa Methods Centre
Ottawa Hospital Research Institute, The Ottawa Hospital

Associate Professor, School of Epidemiology and Public Health
Faculty of Medicine, University of Ottawa

Adjunct Scientist, Chronic Disease Program
ICES (Institute of Clinical Evaluative Sciences)

Member, Centre for Implementation Research
Ottawa Hospital Research Institute

Visiting Professor, Faculty of Pharmacy
Chiang Mai University, Thailand

• Health Economics
• Health Technology Assessment
• Pharmacoepidemiology
• Health Services Research
• Health Equity/Access to care
• Care for People with Complex Needs
• Global Health
• Population Health

More information about the Centre for Implementation Research 

Dr. Kednapa Thavorn is a Senior Scientist and a Scientific Lead of Health Economics at the Ottawa Hospital Research Institute. She is also an Associate Professor with the School of Epidemiology and Public Health at the University of Ottawa, an Adjunct Scientist at ICES (Full Status), and a Visiting Professor at the Faculty of Pharmacy, Chiang Mai University, Thailand. She holds a Ph.D. in Health Services Research from the Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto. She completed post-doctoral fellowship programs in Applied Pharmacoeconomics from the Li Ka Shing Knowledge Institute, St. Michael’s Hospital and Health Services Research from the IHPME, University of Toronto.

Her research focuses on health economics, health technology assessment, pharmacoepidemiology, health equity, care for people with complex needs, and population health. As a health economist, she has collaborated with patient partners, clinicians, researchers, and policymakers in Canada and other countries on various health services research and health technology assessment projects.

Papers in refereed journals: (N=277)

1. Thavorn K, Thompson E, Kumar S, Heiskanen A*, Agarwal A*, Atkins H, Shorr R, Hawrysh T, Chan KKW, Presseau J, Ollendorf DA, Graham ID, Grimshaw JM, Lalu MM, Nochaiwong S, Fergusson D, Hutton B, Coyle D, Kekre N. Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review. Value in Health. April 7, 2024. https://doi.org/10.1016/j.jval.2024.04.004
   
   
2. Mahmoud HA*, Thavorn K, Mulpuru S, McIsaac D, Abdelrazek MA, Mahmoud AA, Forster AJ. Barriers and facilitators to improving patient safety learning systems: a systematic review of qualitative studies and meta-synthesis. BMJ Open Qual 2023 ;12(2):e002134. doi: 10.1136/bmjoq-2022-002134
   
   
3. Mital S, Kelly D, Hughes C, Nosyk B, Thavorn K, Nguyen HV. Estimated cost-effectiveness of point-of-care testing in community pharmacies versus self-testing and standard laboratory testing for HIV. AIDS. 2023 Feb 17. doi: 10.1097/QAD.0000000000003526.
   
   
4. Kekre N, Hay KA, Webb JR, Mallick R, Balasundaram M, Sigrist MK, Clement AM, Nielsen JS, Quizi J, Yung E, Brown SD, Dreolini L, Waller DD, Smazynski J, Gierc NS, Loveless BC, Clark K, Dyer T, Hogg R, McCormick L, Gignac M, Bell S, Chapman DM, Bond D, Yong S, Fung R, Lockyer HM, Hodgson V, Murphy C, Subramanian A, Wiebe E, Yoganathan P, Medynski L, Vaillan DC, Black A, McDiarmid S, Kennah M, Hamelin L, Song K, Narayanan S, Rodrigo JA, Dupont S, Hawrysh T, Presseau J, Thavorn K, Lalu MM, Fergusson DA, Bell JC, Atkins H, Nelson BH, Holt RA. CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies. Front Immunol. 2022;13:1074740. doi: 10.3389/fimmu.2022.1074740
   
   
5. Nochaiwong S, Ruengorn C, Awiphan R, Chai-Adisaksopha C, Sood MM, Hutton B, Thavorn K. Use of Serotonin Reuptake Inhibitor Antidepressants Concomitant with Antithrombotic Therapy and the Risk of Bleeding Complications: A Systematic Review and Meta-Analysis. Annals of Medicine. 2021;54(1):80-97. doi: 10.1080/07853890.2021.2017474 

Cancer; COVID-19; Diabetes; Gastrointestinal disease; Glaucoma; Global health; Health equity; Health in disadvantaged peoples; Health in older peoples; HIV; Immigrant and refugee health; Population health; Septic shock; Stroke; Thrombosis / thromboembolism; Vision

Clinical research; Cohort studies; Epidemiology; Health economics; Health research methods; Health services research; Knowledge translation and implementation research; Patient engagement; Pharmacy; Public health; Quality Improvement; Systematic reviews